[1] JADHAV A N, DASH R C, HIRWANI R R. Relative stability of thrombin-hirudin complex is illustrated using molecular dynamics[J]. Journal of Computational Methods in Molecular Design, 2014, 4(4):54-62.
[2] 李秋菊, 王巍, 马红霞,等. 抗凝血酶概述[J]. 动物医学进展, 2011, 32(9):106-109. LI Q J, WANG W, MA H X, et al.Antithrombin overview[J]. Progress in Veterinary Medicine, 2011, 32(9):106-109. (in Chinese)
[3] LI J, LIU F, QIN Y, et al. A novel natural hirudin facilitated anti-clotting polylactide membrane via hydrogen bonding interaction[J]. Journal of Membrane Science, 2017, 523:505-514.
[4] PATEL V P, BONG M, DI C P. Heparin-induced thrombocytopenia and thrombosis[J]. American Journal of Orthopedics, 2007, 36(5):255.
[5] VARGAS H O, VON-HEYMANN C, LIPPS M, et al. Hirudin versus heparin for anticoagulation in continuous renal replacement therapy[J]. Intensive Care Medicine, 2001, 27(4):673-679.
[6] 张颖, 冯加纯, 吴江, 等. 水蛭素对大鼠实验性脑出血急性期保护作用的研究[J]. 中国中药杂志, 2006, 31(1):69-72. ZHANG Y, FENG J C, WU J, et al.Study on the protective effect of hirudin on acute cerebral hemorrhage in rats[J]. Chinese Journal of Traditional Chinese Medicine, 2006, 31(1):69-72.(in Chinese)
[7] 徐海燕, 陈学勋, 刘蒙蒙,等. 水蛭素对肾病综合征患者凝血酶激活的纤溶抑制物的影响及疗效观察[J]. 中成药, 2015, 37(4):918-921. XU H Y, CHEN X X, L M M, et al. Hirudin and the like and efficacy of nephrotic patients thrombin-activatable fibrinolysis inhibitor observation[J].Syndrome Medicine, 2015, 37(4):918-921. (in Chinese)
[8] 郭睿, 农晓琳, 邓凌,等. 水蛭素对皮肤增生性瘢痕成纤维细胞bFGF及TGFβ-1表达的影响[J]. 中国美容医学杂志, 2011, 20(4):614-617. GUO R, NONG X L, DENG L, et al. Hirudin and other skin hypertrophic scar fibroblasts and expression of bFGF TGFβ-1[J].Chinese Journal of Aesthetic Medicine, 2011, 20(4):614-617. (in Chinese)
[9] MüLLER C, HAASE M, LEMKE S, et al. Hirudins and hirudin-like factors in Hirudinidae:Implications for function and phylogenetic relationships[J]. Parasitology Research, 2017, 116(1):313-325.
[10] MüLLER C, MESCKE K, LIEBIG S, et al. More than just one:Multiplicity of hirudins and hirudin-like factors in the medicinal leech, Hirudo medicinalis[J]. Molecular Genetics and Genomics, 2016, 291(1):227.
[11] ASGARI S, MIRZAHOSEINI H, KARIMIPOUR M, et al. Rational design of stable and functional hirudin Ⅲ mutants with lower antigenicity[J]. Biologicals, 2015, 43(6):479-491.
[12] XIN X, LIU W, SUN L. Improving the bioactivity of rHirudin with boronophenylalanine site-specific modification[J]. Molecular Medicine Reports, 2015, 11(5):3774-3779.
[13] WAGNER J M, ALPER H S. Synthetic biology and molecular genetics in non-conventional yeasts:Current tools and future advances[J]. Fungal Genetics and Biology, 2016, 89:126-136.
[14] JOSHI M, SODHI K S, PANDEY R, et al. Transgenic plants as sole source for biopharmaceuticals[J].International Journal of Recent Trends in Science and Technology,2014,13(1):97-106.
[15] GUO C H, OHSAKO T, OZAKI A, et al. Production of transplastomic tobacco plants having a gene encoding hirudine[J]. Breed Research, 2004,6:268-268.
[16] 梁艳, 卢文玉,闻建平. Minitab软件在多杀菌素发酵条件优化中的应用[J]. 中国抗生素杂志, 2008,11:659-662. LIANG Y, LU W Y, WEN J P, Minitab software spinosad fermentation conditions optimization[J]. Chinese Journal of Antibiotics, 2008,11:659-662. (in Chinese)
[17] HATAMI M, CUIJPERS M C M, BOOT M D. Experimental optimization of the vanes geometry for a variable geometry turbocharger (VGT) using a design of experiment (DoE) approach[J]. Energy Conversion and Management, 2015, 106:1057-1070.
[18] LEE S H, PARK J, KIM H R, et al. Synthesis of carbon nanotube fibers using the direct spinning process based on design of experiment (DOE)[J]. Carbon, 2016, 100:647-655.
[19] 张超, 巩蔚, 郭莹莹,等. 重组抗凝蛋白-新蛭素的原核表达研究[J]. 中国生物工程杂志, 2014, 34(12):69-77. ZHANG C, GONG W, GUO Y Y, et al.Prokaryotic expression of recombinant anticoagulant-hirudin[J].Chinese Journal of Biotechnology, 2014, 34(12):69-77. (in Chinese)
[20] DONAHUE R A,BEBEE R L. BL21-SITM competent cells for protein expression in E.coli[J]. Protein Expression and Purification, 1999, 7:289.
[21] LI Y, XIE Y, ZHU L, et al. Optimization of cloning and expression of beta-glucanase gene from Bacillus amyloliquefaciens [J]. Chinese Journal of Biotechnology, 2009, 25(4):542.
[22] ZHENG C, ZHAO Z, LI Y, et al. Effect of IPTG amount on apo-and holo-forms of glycerophosphate oxidase expressed in Escherichia coli[J]. Protein Expression & Purification, 2011, 75(2):133-137.
[23] 范芳芳, 孙慧莹, 徐晖,等. 重组阳离子抗肿瘤肽AIK的原核表达、纯化及活性测定[J]. 生物工程学报, 2015, 31(12):1753-1763. FAN F F,SUN H Y,XU H, et al. Prokaryotic expression, purification and activity determination of recombinant cationic antitumor peptide AIK[J].Chinese Journal of Biotechnology, 2015, 31(12):1753-1763. (in Chinese)
[24] 彭传林, 魏川川, 吴建伟,等. 家蝇抗真菌肽MAF-1原核表达条件优化及活性验证[J]. 中国公共卫生, 2015, 31(11):1420-1423. PENG C L,WEI C C,WU J W, et al. Optimization of prokaryotic expression conditions and activity of housefly antifungal peptide MAF-1[J]. Chinese Journal of Public Health, 2015,31(11):1420-1423. (in Chinese)
[25] 梁艳, 卢文玉, 闻建平. Minitab软件在多杀菌素发酵条件优化中的应用[J]. 中国抗生素杂志, 2008, 11:659-662. LIANG Y, LU W Y, WEN J P. Minitab software spinosad fermentation conditions optimization[J]. Chinese Journal of Antibiotics, 2008, 11:659-662. (in Chinese)
[26] 何佳鲜, 江雷雨, 洪敏, 等. 草莓FaMYB5基因原核表达的响应面优化[J]. 基因组学与应用生物学, 2017, 36(1):388-394. HE J X, JIANG L Y, HONG M, et al. Response surface optimization of prokaryotic expression of strawberry FaMYB5 gene[J]. Genomics and Applied Biology, 2017, 36(1):388-394. (in Chinese)
[27] 李红, 刘成倩, 严华祥,等. 猪干扰素-δ基因原核表达载体的构建及高效表达[J]. 中国畜牧兽医, 2016, 43(4):940-945. LI H, LIU C Q, YAN H X,et al. Construction of prokaryotic expression vector of porcine interferon-δ gene and its efficient expression[J].Animal Husbandry & Veterinary China, 2016, 43(4):940-945. (in Chinese)
[28] 林陈水,陈微微. 分泌型水蛭素Ⅱ基因工程菌的构建[J]. 浙江工业大学学报, 2014,1:50-53. LIN C S, CHEN W W. Construction of secretory hirudin Ⅱ gene engineering bacteria[J]. Zhejiang University of Technology, 2014,1:50-53. (in Chinese) |